glp 1 drugs and crohn's disease Cary Gastroenterology Associates GLP-1 based therapies and disease

Flu like symptoms can last up to 24 hours when given IV

For clinicians, we hope these findings may prompt a more thoughtful, individualized approach when considering these therapies in higher-risk patients who have both obesity and autoimmune disease. I am excited about the combination of medications for these diseases pairing medicines with known benefits to treat the autoimmune disease with a GLP-1RA, said Sheer

Our dedicated medical team takes the time to educate and guide you, ensuring you understand the difference between naturally occurring GLP-1 and pharmaceutical interventions designed to enhance your health

Please follow your physicians mixing and dosing instructions if they differ from the ones we have listed above

The BSH recommends that treatment decisions should be based on clinical presentation rather than borderline laboratory values alone